NCT03611426View on ClinicalTrials.gov

Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

December 5, 2018

Study Completion Date

July 30, 2019

Conditions
Hepatectomy
Interventions
DRUG

rhThrombin ( Topical )

Active Substance

DRUG

placebo

saline solution

Trial Locations (1)

310000

Zhiwei Li, Hangzhou

All Listed Sponsors
lead

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

INDUSTRY

NCT03611426 - Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy | Biotech Hunter | Biotech Hunter